Skip to main content

Main menu

  • Home
  • Issues
    • Issue in progress
    • Issues by date
  • Sections
    • Editorial
    • Review
    • Research
    • Commentary
    • Psychopharmacology for the Clinician
    • Letters to the Editor
  • Topic Collections
  • Instructions for Authors
    • Overview for authors
    • Submission checklist
    • Editorial policies
    • Publication fees
    • Submit a manuscript
    • Dr. Francis Wayne Quan Memorial Prize
    • Open access
  • Alerts
    • Email alerts
    • RSS
  • About
    • General information
    • Staff
    • Editorial Board
    • Contact
  • CMAJ JOURNALS
    • CMAJ
    • CMAJ Open
    • CJS
    • JAMC

User menu

Search

  • Advanced search
JPN
  • CMAJ JOURNALS
    • CMAJ
    • CMAJ Open
    • CJS
    • JAMC
JPN

Advanced Search

  • Home
  • Issues
    • Issue in progress
    • Issues by date
  • Sections
    • Editorial
    • Review
    • Research
    • Commentary
    • Psychopharmacology for the Clinician
    • Letters to the Editor
  • Topic Collections
  • Instructions for Authors
    • Overview for authors
    • Submission checklist
    • Editorial policies
    • Publication fees
    • Submit a manuscript
    • Dr. Francis Wayne Quan Memorial Prize
    • Open access
  • Alerts
    • Email alerts
    • RSS
  • About
    • General information
    • Staff
    • Editorial Board
    • Contact
  • Subscribe to our alerts
  • RSS feeds
  • Follow JPN on Twitter
Research Paper

Affect, interpersonal behaviour and interpersonal perception during open-label, uncontrolled paroxetine treatment of people with social anxiety disorder: a pilot study

Lance M. Rappaport, Jennifer J. Russell, Donald Hedeker, Gilbert Pinard, Pierre Bleau and Debbie S. Moskowitz
J Psychiatry Neurosci November 01, 2018 43 (6) 407-415; DOI: https://doi.org/10.1503/jpn.170141
Lance M. Rappaport
From the Virginia Institute for Psychiatric and Behavioral Genetics, Department of Psychiatry, Virginia Commonwealth University, Richmond, Va. (Rappaport); the Department of Psychology, McGill University, Montréal, Que. (Rappaport, Russel, Moskowitz); the Department of Psychiatry, McGill University, Montréal, Que. (Russel, Pinard, Bleau); and the Department of Public Health Sciences, University of Chicago, Chicago, Il. (Hedeker)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jennifer J. Russell
From the Virginia Institute for Psychiatric and Behavioral Genetics, Department of Psychiatry, Virginia Commonwealth University, Richmond, Va. (Rappaport); the Department of Psychology, McGill University, Montréal, Que. (Rappaport, Russel, Moskowitz); the Department of Psychiatry, McGill University, Montréal, Que. (Russel, Pinard, Bleau); and the Department of Public Health Sciences, University of Chicago, Chicago, Il. (Hedeker)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Donald Hedeker
From the Virginia Institute for Psychiatric and Behavioral Genetics, Department of Psychiatry, Virginia Commonwealth University, Richmond, Va. (Rappaport); the Department of Psychology, McGill University, Montréal, Que. (Rappaport, Russel, Moskowitz); the Department of Psychiatry, McGill University, Montréal, Que. (Russel, Pinard, Bleau); and the Department of Public Health Sciences, University of Chicago, Chicago, Il. (Hedeker)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gilbert Pinard
From the Virginia Institute for Psychiatric and Behavioral Genetics, Department of Psychiatry, Virginia Commonwealth University, Richmond, Va. (Rappaport); the Department of Psychology, McGill University, Montréal, Que. (Rappaport, Russel, Moskowitz); the Department of Psychiatry, McGill University, Montréal, Que. (Russel, Pinard, Bleau); and the Department of Public Health Sciences, University of Chicago, Chicago, Il. (Hedeker)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Pierre Bleau
From the Virginia Institute for Psychiatric and Behavioral Genetics, Department of Psychiatry, Virginia Commonwealth University, Richmond, Va. (Rappaport); the Department of Psychology, McGill University, Montréal, Que. (Rappaport, Russel, Moskowitz); the Department of Psychiatry, McGill University, Montréal, Que. (Russel, Pinard, Bleau); and the Department of Public Health Sciences, University of Chicago, Chicago, Il. (Hedeker)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Debbie S. Moskowitz
From the Virginia Institute for Psychiatric and Behavioral Genetics, Department of Psychiatry, Virginia Commonwealth University, Richmond, Va. (Rappaport); the Department of Psychology, McGill University, Montréal, Que. (Rappaport, Russel, Moskowitz); the Department of Psychiatry, McGill University, Montréal, Que. (Russel, Pinard, Bleau); and the Department of Public Health Sciences, University of Chicago, Chicago, Il. (Hedeker)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Tables
  • Related Content
  • Responses
  • Metrics
  • PDF
Loading

Article Figures & Tables

Figures

  • Tables
  • Fig. 1
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 1

    Changes in symptom severity (A, B) and event-level affect mean and variability (C, D). LSAS = Liebowitz Social Anxiety Scale; MADRS = Montgomery–Åsberg Depression Rating Scale; SIAS = Social Interaction and Anxiety Scale; SPS = Social Phobia Scale.

  • Fig. 2
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 2

    Changes in mean and variability of participants’ perception of others’ behaviour (A, B) and participants’ own interpersonal behaviour (C, D).

Tables

  • Figures
    • View popup
    Table 1

    Change in anxiety and depression symptom severity over treatment

    ScaleIntercept, B (95% CI)Linear slope, B (95% CI)Quadratic slope, B (95% CI)
    Liebowitz Social Anxiety Scale116.38*** (106.31 to 126.45)−35.52*** (−43.06 to −27.97)4.03*** (2.81 to 5.25)
    Social Phobia Scale61.85*** (55.65 to 68.05)−18.26*** (−22.19 to −14.33)2.01*** (1.39 to 2.63)
    Social Interaction and Anxiety Scale63.96*** (59.16 to 68.76)−17.67*** (−21.34 to −14.01)1.92*** (1.34 to 2.50)
    Montgomery–Åsberg Depression Rating Scale9.74*** (6.91 to 12.57)−3.07** (−5.25 to −0.89)0.34 (−0.02 to 0.70)
    • CI = confidence interval.

    • ↵** p ≤ 0.01;

    • ↵*** p ≤ 0.001.

    • For random-effect estimates, see Appendix 1, Table S1, available at jpn.ca/170141-a1.

    • View popup
    Table 2

    Change in affect, perception and interpersonal behaviour over treatment, mean (location) and variance (scale)

    MeanVariance
    MeasureIntercept, B/σ2 (95% CI)Linear slope, B/σ2 (95% CI)Quadratic slope, B/σ2 (95% CI)Cubic slope, B/σ2 (95% CI)Intercept, B/σ2 (95% CI)Linear slope, B/σ2 (95% CI)
    Positive affect2.21*** (1.89 to 2.52)0.47*** (0.29 to 0.65)−0.08*** (−0.13 to −0.04)—0.18 (−0.01 to 0.37)−0.15*** (−0.19 to −0.11)
    Negative affect1.32*** (1.12 to 1.51)−0.51*** (−0.62 to −0.39)0.08*** (0.06 to 0.11)—−0.18 (−0.49 to 0.13)−0.47*** (−0.51 to −0.44)
    Perception of warmth7.39*** (7.02 to 7.75)0.67*** (0.41 to 0.93)−0.10** (−0.16 to −0.04)—1.76*** (1.56 to 1.97)−0.18*** (−0.22 to −0.14)
    Perception of dominance7.63*** (7.37 to 7.88)———1.56*** (1.36 to 1.77)−0.23*** (−0.27 to −0.19)
    Agreeable behaviour11.83*** (9.36 to 14.29)5.22*** (2.94 to 7.51)−1.06*** (−1.62 to −0.50)—6.30*** (6.22 to 6.39)−0.05** (−0.08 to −0.01)
    Quarrelsome behaviour−15.21*** (−17.58 to −12.83)−1.82* (−3.47 to −0.17)0.40* (−0.003 to 0.81)—6.00*** (5.84 to 6.16)−0.09*** (−0.13 to −0.06)
    Dominant behaviour−0.88 (−3.68 to 1.92)2.21*** (1.27 to 3.15)——6.30*** (6.20 to 6.39)−0.06** (−0.09 to −0.02)
    Submissive behaviour3.83* (0.47 to 7.18)−14.28*** (−20.05 to −8.51)6.18** (2.45 to 9.91)−0.88** (−1.50 to −0.25)6.52*** (6.41 to 6.64)−0.15*** (−0.19 to −0.12)
    • CI = confidence interval.

    • ↵* p ≤ 0.05;

    • ↵** p ≤ 0.01;

    • ↵*** p ≤ 0.001.

    • Dashes indicate a nonsignificant effect not included in the final model.

    • For random-effect estimates, see Appendix 1, Table S2 and Table S3, available at jpn.ca/170141-a1.

PreviousNext
Back to top

In this issue

Journal of Psychiatry and Neuroscience: 43 (6)
J Psychiatry Neurosci
Vol. 43, Issue 6
1 Nov 2018
  • Table of Contents
  • Table of Contents (PDF)
  • Cover (PDF)
  • Index by author

Article tools

Respond to this article
Print
Download PDF
Article Alerts
To sign up for email alerts or to access your current email alerts, enter your email address below:
Email Article

Thank you for your interest in spreading the word on JPN.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Affect, interpersonal behaviour and interpersonal perception during open-label, uncontrolled paroxetine treatment of people with social anxiety disorder: a pilot study
(Your Name) has sent you a message from JPN
(Your Name) thought you would like to see the JPN web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Affect, interpersonal behaviour and interpersonal perception during open-label, uncontrolled paroxetine treatment of people with social anxiety disorder: a pilot study
Lance M. Rappaport, Jennifer J. Russell, Donald Hedeker, Gilbert Pinard, Pierre Bleau, Debbie S. Moskowitz
J Psychiatry Neurosci Nov 2018, 43 (6) 407-415; DOI: 10.1503/jpn.170141

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
‍ Request Permissions
Share
Affect, interpersonal behaviour and interpersonal perception during open-label, uncontrolled paroxetine treatment of people with social anxiety disorder: a pilot study
Lance M. Rappaport, Jennifer J. Russell, Donald Hedeker, Gilbert Pinard, Pierre Bleau, Debbie S. Moskowitz
J Psychiatry Neurosci Nov 2018, 43 (6) 407-415; DOI: 10.1503/jpn.170141
Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like

Related Articles

  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

Similar Articles

Content

  • Current issue
  • Past issues
  • Collections
  • Alerts
  • RSS

Authors & Reviewers

  • Overview for Authors
  • Submit a manuscript
  • Manuscript Submission Checklist

About

  • General Information
  • Staff
  • Editorial Board
  • Contact Us
  • Advertising
  • Reprints
  • Copyright and Permissions
  • Accessibility
  • CMA Civility Standards
CMAJ Group

Copyright 2023, CMA Impact Inc. or its licensors. All rights reserved. ISSN 1180-4882.

All editorial matter in JPN represents the opinions of the authors and not necessarily those of the Canadian Medical Association or its subsidiaries.
To receive any of these resources in an accessible format, please contact us at CMAJ Group, 500-1410 Blair Towers Place, Ottawa ON, K1J 9B9; p: 1-888-855-2555; e: [email protected].
View CMA's Accessibility policy.

Powered by HighWire